Biopharma: Optibrium and Bugworks Sign Agreement for StarDrop License
CAMBRIDGE, United Kingdom & BENGALURU, India-(BUSINESS WIRE)-Optibrium , a developer of software for small molecule discovery, and Bugworks Research Inc. (Bugworks), a company focused on discovering biopharmaceuticals for the treatment of critical and serious bacterial infections,...
Read full article »
CEO
Biopharma is a Private company. Biopharma has an estimated revenue of <$1M and an estimate of less <10 employees.